AutoTrader will notify you when there is a new listing for this search.

JPMorgan analysts earlier this identified the conference as a likely catalyst for Viking shares, with production and sale of the treatment likely several clinical trials and years away.

We couldn't find what you’re looking for right now ...

Viking’s results provided the latest showcase of how much Wegovy and Zepbound’s market success has heightened investor attention on preliminary findings from small studies. The data are from a Phase 1 ...

We couldn't find what you’re looking for right now ...

William Blair notes that VK2735 stands out as a promising candidate for big pharma due to its Phase 3 readiness, the potential for tablet formulation, and Viking’s amylin program, which is set ...

The data released by Viking showed that adults taking the highest dosage of the oral VK2735 tablet lost an average of 8.2% of their body weight in just four weeks, or 6.8% more than those that ...

The tank is layered with Viking shields, inspired by the series, on its support rollers and side screens, while Ragnar Lothbrok’s axe and a Carolingian sword evoke the power of the Viking warriors.

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for its experimental obesity pill, with increased weight loss observed at ...

Pills that work similarly to currently available injectable medications represent the next wave of metabolic disorder drugs, and Viking Therapeutics is pushing its drug candidate to the forefront ...

Lois Borny works on the product review section of The Independent, IndyBest, where she helps readers to save money and shop savvy, scouting out the very best deals and sharing her tried and tested ...